Antibiotics usage in infants during the first 18 months of life in Benin: a population-based cohort study
A Brembilla1,2, F Mauny3,4, A Garcia5,6
1Laboratoire Chrono-Environnement UMR CNRS 6249, Université Bourgogne Franche-Comté, 25000, Besançon, France. alice.brembilla@gmail.com.
Insights
Antibiotic prescriptions (ABPr) in African infants are common, especially for those over six months with respiratory or enteric symptoms. Malaria was linked to lower ABPr, highlighting the need for rational antibiotic use guidelines.
Area of Science:
- Pediatric infectious diseases
- Antimicrobial stewardship
- Global health
Background:
- Limited data exists on antibiotic usage patterns and determinants in African pediatric populations.
- Understanding these factors is crucial for combating antimicrobial resistance.
Purpose of the Study:
- To define the determinants of antibiotic prescriptions (ABPr) in a birth cohort of infants in Benin.
- To identify key factors influencing antibiotic prescribing practices in this setting.
Main Methods:
- A prospective birth cohort study followed 538 infants from birth to 18 months in three health centers (2007-2009).
- Data collected included infant clinical findings, maternal/child characteristics, and general health parameters.
- Multilevel logistic regression models were employed for data analysis.
Main Results:
- Antibiotics were prescribed in 44.2% of 4394 consultations, with significant variation between health centers.
- Nearly 40% of ABPr occurred in children without fever; rates were higher after six months of age.
- Respiratory and enteric symptoms were associated with increased ABPr, while malaria was associated with decreased ABPr (OR=0.55).
- Low breastfeeding scores were positively associated with ABPr.
Conclusions:
- Antibiotic prescribing in Benin infants is influenced by age, symptoms (respiratory/enteric), and malaria status.
- Interventions should target children over six months, those without malaria, and those with specific symptoms.
- Further research is needed to improve healthcare provider adherence to antibiotic usage guidelines.
Abstract:
Data centered on antibiotics usage and their determinants in African pediatric populations are limited. In order to define the determinants of antibiotics prescriptions (ABPr), we analyzed the data of a birth cohort in Benin. From 2007 to 2009, 538 infants were followed from birth to 18 months in three different health centers. The following determinants were assessed: infants' clinical findings at consultations, mothers' and children's characteristics at birth, and health parameters recorded at scheduled follow-up of general health parameters. Multilevel logistic models were performed for analysis. Among the 4394 consultations, fever represented 53.7 % of consultations, 64.1 % of which were non-malarial fevers. Antibiotics were prescribed during 44.2 % of the consultations and the proportion of ABPr differed significantly among health centers (p < 10(-3)). Nearly 40 % of ABPr were related to children without fever. During the first semester of life, the percentage of ABPr was twice lower than after (27.4 vs. 54.7, p < 10(-3)). Respiratory and enteric symptoms were positively associated with ABPr (p < 10(-3)). Malaria was significantly associated with a lower ABPr after the first semester [odds ratio (OR) = 0.55, 95 % confidence interval (CI) = 0.44-0.67, p < 10(-3)]. No maternal and child at-birth characteristics were associated with ABPr. ABPr was positively associated with a low breastfeeding score (p < 10(-3)). Studies on the rational use of antibiotics in this population should give priority to children more than 6 months of age, without malaria, and with respiratory and/or enteric symptoms. Our data also advocate for studies specifically designed to assess and improve healthcare providers' compliance to guidelines on antibiotics usage.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Antibiotic Selection
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Development of Human Microbiota


